Dr. Luke Stoeckel, PhD, is a clinical neuropsychologist, neuroscientist, and program director in the Division of Behavioral and Social Research (BSR) at the National Institute on Aging (NIA). Dr. Stoeckel’s portfolio includes research on decision science of aging, including integrative neuroscience, especially in the area of decision neuroscience of aging; prediction of behavior and neuropsychological and behavioral phenotypes relevant to the decision science of aging; mechanisms of behavior change relevant to the decision science of aging; the development and refinement of taxonomies, ontologies, and measurement efforts relevant to the decision science of aging; and psychological, including neuropsychological, COVID-19-related research. Activities in these areas focus on normal aging and Alzheimer’s Disease and Alzheimer’s Disease-related Dementias (AD/ADRD). Dr. Stoeckel has an AB in Psychology from Harvard College, PhD in Medical (Clinical) Psychology from the University of Alabama at Birmingham and he completed internship and postdoctoral training in clinical neuropsychology and cognitive neuroscience at Massachusetts General Hospital (MGH) and Harvard Medical School (HMS). Prior to joining the NIA, he was the Director of the Cognitive and Clinical Neuroscience of Obesity and Diabetes program at the National Institute of Diabetes and Digestive and Kidney Diseases. Prior to joining the NIH, he was the Director of Clinical Neuroscience at the MGH Center for Addiction Medicine, Assistant Professor of Psychology in the Department of Psychiatry at HMS, and a Research Affiliate at the Martinos Center for Biomedical Imaging, McLean Hospital, and the McGovern Institute for Brain Research at the Massachusetts Institute of Technology.

NIA Biography: https://www.nia.nih.gov/about/staff/stoeckel-luke
Google Scholar: https://scholar.google.com/citations?user=hTGh2hoAAAAJ&hl=en